Advances in Breast Cancer Treatment
C. Kent Osborne, M.D., FASCO
April 16, 2018

Save as Favorite
Sign in to receive recommendations (Learn more)
Osborne kent

Dr. C. Kent Osborne is director of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine, where he is also a professor and the Dudley and Tina Sharp Chair for Cancer Research. Since 1992, he has been a codirector of the San Antonio Breast Cancer Symposium, the world's largest conference focusing entirely on breast cancer. His own research focuses on improving the effectiveness of hormonal therapy medicines and targeted therapies that treat HER2-positive disease. At the 2018 American Association for Cancer Annual Meeting, Dr. Osborne was honored with the 2018 AACR Distinguished Award for Extraordinary Scientific Achievement and Leadership in Breast Cancer Research, in part for his stewardship of the San Antonio Symposium.

Listen to the podcast to hear Dr. Osborne discuss:

  • how our understanding of breast cancer has changed since the 1970s
  • the most promising areas of breast cancer research going on right now
  • the feasibility of a cure for breast cancer

Running time: 12:06

Lilly.podcastsupportrecognition

Show Full Transcript

Coming soon.

Hide Transcript


Was this article helpful? Yes / No

Supportpeopleyellow banner mini
Back to Top